The Danish Medicines Agency has received the first report on a possible case of severe blood clots under the optional scheme with the Janssen vaccine.
It should be about the condition WHITE, which is characterized by blood clots, bleeding and low platelet counts, writes DR.
– After an urgent processing of the documentation, the board’s assessment is that it is probably a question of VITT, says Line Michan, unit manager for pharmacovigilance at the Norwegian Medicines Agency.
It is in a Danish woman of 29 years where the case has been discovered, according to DR’s information.
This is the first reported case of such a disease associated with the Janssen vaccine in Denmark.
Also read: Denmark: Infection rates and hospital admissions increase
More than 40,000 people have received the Janssen vaccine in Denmark. The vaccine is being developed by the American pharmaceutical company Johnson & Johnson.
In Norway, the Janssen vaccine was removed from the Norwegian vaccine program following reports of serious side effects, but like Denmark, it is also open in this country for it to be given to volunteers when strict health criteria are met.
–
